medicineのメーカーや取扱い企業、製品情報、参考価格、ランキングをまとめています。
イプロスは、 製造業 ・ BtoB における情報を集めた国内最大級の技術データベースサイトです。

medicine - メーカー・企業37社の製品一覧とランキング

更新日： 集計期間:Dec 31, 2025～Jan 27, 2026
※当サイトの各ページの閲覧回数を元に算出したランキングです。

medicineのメーカー・企業ランキング

更新日： 集計期間:Dec 31, 2025～Jan 27, 2026
※当サイトの各ページの閲覧回数を元に算出したランキングです。

  1. マーケットリサーチセンター Tokyo//Service Industry
  2. KANTO CHEMICAL CO., INC. Biochemical Dept Tokyo//Chemical
  3. null/null
  4. 4 大塚化学 Tokyo//Chemical
  5. 4 Tohoku Techno Arch Co., Ltd. Miyagi//Educational and Research Institutions
企業ランキングへ

medicineの製品ランキング

更新日： 集計期間:Dec 31, 2025～Jan 27, 2026
※当サイトの各ページの閲覧回数を元に算出したランキングです。

  1. For various titrations! The titration "indicator" specified in JIS K8001. KANTO CHEMICAL CO., INC. Biochemical Dept
  2. Pharmaceutical CDMO services 大塚化学
  3. Natural Proteoglycan, the Herbal Medicine of the Sea バイオマテックジャパン
  4. 4 Ouchi Shinko Chemical Industry Co., Ltd. 須賀川市 経済環境部商工課
  5. 5 Contract development and manufacturing (CDMO) business for mid-sized molecules (oligonucleotides and peptides) active pharmaceutical ingredients.

medicineの製品一覧

301～315 件を表示 ／ 全 589 件

表示件数
[Research Material] The Global Market for Angina Treatment

[Research Material] The Global Market for Angina Treatment

Global Market for Angina Pectoris Treatment: Antiplatelet Drugs, Beta-Adrenergic Blockers, Calcium Channel Blockers, Short-Acting and Long-Acting Nitroglycerin...

This research report (Global Angina Pectoris Treatment Market) investigates and analyzes the current state and outlook for the global angina pectoris treatment market over the next five years. It includes information on the overview of the global angina pectoris treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the angina pectoris treatment market include antiplatelet drugs, beta-adrenergic blockers, calcium channel blockers, short-acting and long-acting nitroglycerin, angiotensin-converting enzyme (ACE) inhibitors, and anti-ischemic drugs. The segments by application focus on hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for angina pectoris treatment. It also includes the market share of major companies in angina pectoris treatment, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for Retinal Therapeutics

[Research Material] Global Market for Retinal Therapeutics

World Market for Retinal Therapeutics: Wet AMD, Diabetic Retinopathy, DME, RVO, Mcnv, Hospitals, Clinics, Others

This research report (Global Retinal Drugs Market) investigates and analyzes the current state and outlook for the global market for retinal therapeutic drugs over the next five years. It includes information on the overview of the global retinal therapeutic drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include wet AMD, diabetic retinopathy, DME, RVO, and Mcnv, while the segments by application focus on hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for retinal therapeutic drugs. It also includes the market share of major companies in retinal therapeutic drugs, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] The Global Market for Alcoholic Liver Disease Treatment

[Research Material] The Global Market for Alcoholic Liver Disease Treatment

Global Market for Alcoholic Liver Disease Treatment: Alcoholic Fatty Liver Disease, Alcoholic Hepatitis, Others, Hospital Pharmacies, Retail Pharmacies, Drugstores ...

This research report (Global Alcoholic Liver Diseases Treatment Market) investigates and analyzes the current status and outlook for the global market for alcoholic liver disease treatment over the next five years. It includes information on the overview of the global alcoholic liver disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the alcoholic liver disease treatment market include alcoholic fatty liver disease, alcoholic hepatitis, and others, while the segments by application include hospital pharmacies, retail pharmacies, drugstores, online pharmacies, and others. The regional segments are classified into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for alcoholic liver disease treatment. It also includes the market share of major companies in the alcoholic liver disease treatment sector, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for Gaucher Disease (GD) Treatments

[Research Material] Global Market for Gaucher Disease (GD) Treatments

Global Market for Gaucher Disease (GD) Treatments: Enzyme Replacement Therapy, Substrate Reduction Therapy, Non-Neuropathic Gaucher Disease, Neuropathic Gaucher Disease

This research report (Global Gaucher Disease (GD) Drugs Market) investigates and analyzes the current status and future outlook of the global market for Gaucher disease (GD) treatment drugs over the next five years. It includes information on the overview of the global Gaucher disease (GD) treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for Gaucher disease (GD) treatment drugs by type include enzyme replacement therapy and substrate reduction therapy, while the segments by application focus on non-neuropathic Gaucher disease and neuropathic Gaucher disease. The regional segments calculate the market size for Gaucher disease (GD) treatment drugs by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the Gaucher disease (GD) treatment drug sector, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for Ulnar Nerve Treatment

[Research Material] Global Market for Ulnar Nerve Treatment

Global Market for Ulnar Nerve Treatment: OTC Pain Relievers, Anticonvulsants, Physical Therapy, Surgery, Hospitals, Clinics, Research Centers, Others

This research report (Global Ulnar Nerve Treatment Market) investigates and analyzes the current status and outlook for the global ulnar nerve treatment market over the next five years. It includes information on the overview of the global ulnar nerve treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the ulnar nerve treatment market include OTC pain relievers, anticonvulsants, physical therapy, and surgery, while the segments by application focus on hospitals, clinics, research centers, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for ulnar nerve treatment. It also includes the market share of major companies in ulnar nerve treatment, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
Global Market for Non-Alcoholic Steatohepatitis (NASH) Treatment

Global Market for Non-Alcoholic Steatohepatitis (NASH) Treatment

Global Market for Non-Alcoholic Steatohepatitis (NASH) Treatment: Off-Label, Therapeutics, Hospital Pharmacies, Online Providers, Retail Pharmacies

This research report (Global Non-Alcoholic Steatohepatitis (NASH) Treatment) investigates and analyzes the current status and outlook for the global market for non-alcoholic steatohepatitis (NASH) treatment over the next five years. It includes information on the overview of the global non-alcoholic steatohepatitis (NASH) treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for non-alcoholic steatohepatitis (NASH) treatment by type focus on off-label and therapeutic drugs, while the segments by application target hospital pharmacies, online providers, and retail pharmacies. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for non-alcoholic steatohepatitis (NASH) treatment. It also includes the market share of major companies in non-alcoholic steatohepatitis (NASH) treatment, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] The Global Market for Dental Infection Treatment

[Research Material] The Global Market for Dental Infection Treatment

Global Market for Dental Infection Treatment: Periodontal Abscess, Periodontal Abscess, Others, Dental Clinics, Hospitals, Others

This research report (Global Dental Infection Treatment Market) investigates and analyzes the current state and outlook for the global dental infection treatment market over the next five years. It includes information on the overview of the global dental infection treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the dental infection treatment market include periodontal abscess, dental abscess, and others, while the segments by application include dental clinics, hospitals, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for dental infection treatment. It also includes the market share of major companies in dental infection treatment, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] The Global Market for Alzheimer's Disease Treatments

[Research Material] The Global Market for Alzheimer's Disease Treatments

World Market for Alzheimer's Disease Treatments: Donepezil, Memantine, Rivastigmine, Early to Moderate Stage, Moderate to Severe Stage

This research report (Global Alzheimer’s Therapeutics Market) investigates and analyzes the current state and outlook for the global market for Alzheimer’s disease treatments over the next five years. It includes information on the overview of the global Alzheimer’s disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Donepezil, Memantine, and Rivastigmine, while the segments by application focus on early to moderate stages and moderate to severe stages. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Alzheimer’s disease treatments. It also includes the market share of major companies in Alzheimer’s disease treatments, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
Global Market for Stroke Prevention in Atrial Fibrillation (SPAF) Treatment

Global Market for Stroke Prevention in Atrial Fibrillation (SPAF) Treatment

Global Market for Stroke Prevention in Atrial Fibrillation (SPAF) Treatment: Oral Direct Thrombin Inhibitors, Oral Direct Factor Xa Inhibitors, Hospitals, Clinics ...

This research report (Global Stroke Prevention in Atrial Fibrillation (SPAF)) investigates and analyzes the current state and future outlook of the global market for stroke prevention in the treatment of atrial fibrillation (SPAF) over the next five years. It includes information on the overview of the global stroke prevention market in atrial fibrillation (SPAF) treatment, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for stroke prevention in atrial fibrillation (SPAF) treatment by type focus on oral direct thrombin inhibitors and oral direct factor Xa inhibitors, while the segments by application target hospitals, clinics, and outpatient surgical centers. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for stroke prevention in atrial fibrillation (SPAF) treatment. It also includes the market share of major companies in stroke prevention for atrial fibrillation (SPAF) treatment, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Market Report] Global Market for Point-of-Care Diagnostic Tests

[Market Report] Global Market for Point-of-Care Diagnostic Tests

With the rapid increase in demand for swift and accurate testing, the global market for POC (point-of-care) diagnostic tests is experiencing rapid growth.

The global POC market is experiencing unprecedented growth due to the increasing demand for rapid and accurate testing solutions. Point-of-care diagnostic tests, also known as bedside testing or near-patient testing, enable timely decision-making by healthcare professionals and improve patient outcomes through rapid diagnosis and treatment. As the value of rapid and accurate testing is recognized by healthcare institutions worldwide in enhancing patient care and streamlining healthcare delivery, the global POC market is poised for continued growth. Please check the application method from the [PDF download] button or apply directly through the related links.

  • others

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Market Report] Global Organ Transplant Rejection Treatment Drug Market

[Market Report] Global Organ Transplant Rejection Treatment Drug Market

The global market for organ transplant rejection treatment drugs is rapidly expanding and is expected to reach 7 billion USD by 2031.

The global organ transplant rejection treatment drug market recorded a market size of 4.9 billion USD in 2022 and is expected to see significant expansion. It is projected to grow at a compound annual growth rate (CAGR) of 3.9% during the forecast period from 2023 to 2031, reaching an estimated value of 7 billion USD by 2031. The driving forces behind this growth are the increase in organ transplant surgeries and advancements in immunosuppressive therapies. The growth of the global organ transplant rejection treatment drug market plays a crucial role in enhancing the quality of life for transplant recipients. Continuous technological innovations and advancements will make this market extremely important in ensuring the success of organ transplant surgeries worldwide. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Market Report] Global Market for Neuropathic Pain Medications

[Market Report] Global Market for Neuropathic Pain Medications

The global market for neuropathic pain treatment drugs is expected to rapidly expand to $10.4 billion by 2031, alleviating suffering worldwide.

The global market for neuropathic pain medications is specialized in improving the lives of people suffering from neuropathic pain and has made significant progress. In 2022, this important market generated approximately $5.8 billion in revenue. It is projected to reach an estimated $10.4 billion by 2031, showing a stable compound annual growth rate (CAGR) of 5% during the forecast period from 2023 to 2031. Neuropathic pain is characterized by sharp, stabbing pain and burning sensations, often caused by nerve damage or dysfunction. Neuropathic pain is a complex condition that significantly impacts the quality of life for millions of people worldwide. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.

  • others

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Market Report] Global Market for Psoriasis Treatments

[Market Report] Global Market for Psoriasis Treatments

The global market for psoriasis treatments is expected to rapidly expand, reaching 55.72 billion USD by 2031.

The global market for psoriasis treatments has experienced significant growth and plays a crucial role in addressing this challenging skin condition. In 2022, the market size reached 25.2 billion USD and is projected to reach 55.72 billion USD by 2031. This notable increase indicates a steady compound annual growth rate (CAGR) of 9.3% during the forecast period from 2023 to 2031. Psoriasis is a chronic skin disease affecting millions of people worldwide, characterized by red, itchy, scaly patches on the skin's surface. The increasing prevalence of psoriasis, heightened awareness, and advancements in treatment options are driving the expansion of the psoriasis treatment market. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Market Report] Global Market for Pulmonary Arterial Hypertension

[Market Report] Global Market for Pulmonary Arterial Hypertension

The global market for pulmonary arterial hypertension is projected to reach 10.8 billion dollars by 2031.

The global pulmonary arterial hypertension (PAH) market reached a revenue of $7 billion in 2022 and is aiming for significant growth. Projections indicate that the market will reach $10.8 billion by 2031, with a compound annual growth rate (CAGR) of 5% from 2023 to 2031. This growth reflects the increasing demand for effective treatments for this serious and life-threatening disease. Pulmonary arterial hypertension is a rare but severe condition characterized by high blood pressure in the lungs. It involves narrowing or blockage of the pulmonary arteries and capillaries, leading to increased strain on the heart and gradually worsening symptoms. Without timely and effective treatment, PAH can be life-threatening, highlighting the urgent need for advanced treatment options. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Market Report] Global Diabetic Nephropathy Market

[Market Report] Global Diabetic Nephropathy Market

The global diabetic nephropathy market is advancing in the fight against kidney disease, expected to reach 3.37 billion USD by 2031.

The global diabetic nephropathy market is at the forefront of combating kidney disorders in diabetic patients, offering hope and advanced treatment options. According to recent market reports, the global diabetic nephropathy market generated approximately $2 billion in revenue in 2022 and is estimated to surge to about $3.37 billion by 2031. This noteworthy growth trajectory is driven by a solid annual compound growth rate (CAGR) of 6% projected from 2023 to 2031. Diabetic nephropathy, a long-term kidney disorder, is a significant concern for those living with diabetes. This condition occurs when persistently elevated blood sugar levels cause damage to kidney function. Diabetic nephropathy can affect patients with type 2 diabetes and is primarily characterized by damage to the smallest blood vessels in the kidneys. When these small blood vessels are damaged, proteins begin to leak into the urine from both kidneys, indicating renal dysfunction. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.

  • others

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録

medicineに関連する検索キーワード

COPYRIGHT © 2001-2026 IPROS CORPORATION ALL RIGHTS RESERVED.